Evidence map›Paper›PMID 34267914›Full record

ArticleClinical case reports2021

A rare initial presentation of a thymic neuroendocrine tumor as Cushing's syndrome.

Ahmad S Matarneh, Abdelrahman O Hamad, Mohammad K Hamad, Elhadi B Elouzi, Nabil S Mahmood, Khaled Al-Sawalmeh, Issam Al-Bozom, Mousa S Hussein, Mohamed A Yassin

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ahmad S MatarnehDepartment of Internal Medicine Hamad Medical Corporation Doha Qatar.
Abdelrahman O HamadDepartment of Internal Medicine Hamad Medical Corporation Doha Qatar.
Mohammad K HamadDepartment of Internal Medicine Hamad Medical Corporation Doha Qatar.ORCID https://orcid.org/0000-0001-9739-0073
Elhadi B ElouziDepartment of Endocrinology Hamad Medical Corporation Doha Qatar.
Nabil S MahmoodDepartment of Radiology Hamad Medical Corporation Doha Qatar.
Khaled Al-SawalmehDepartment of Laboratory Medicine and Pathology Hamad Medical Corporation Doha Qatar.
Issam Al-BozomDepartment of Laboratory Medicine and Pathology Hamad Medical Corporation Doha Qatar.
Mousa S HusseinDepartment of Pulmonology Hamad Medical Corporation Doha Qatar.
Mohamed A YassinDepartment of Medical Oncology Hamad Medical Corporation Doha Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While evaluating the cause of Cushing's syndrome, biochemical confirmation should be sought first as imaging studies might misdirect the diagnosis toward the wrong problem. One of the rare secondary causes that should be kept in mind while evaluating Cushing's syndrome is the thymic neuroendocrine tumor.

Indexed as

Cushing's syndromehypercortisolismNeuroendocrine neoplasmpituitary incidentalomathymic malignancies

Identifiers

PMID34267914
PMCPMC8271261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.